Skip to main content
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.41
+0.11 (1.51%)
Nov 21, 2024, 1:12 PM EST - Market open

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $117.09M in the quarter ending September 30, 2024, with 34.98% growth. This brings the company's revenue in the last twelve months to $412.58M, up 29.92% year-over-year. In the year 2023, BioCryst Pharmaceuticals had annual revenue of $331.41M with 22.37% growth.

Revenue (ttm)
$412.58M
Revenue Growth
+29.92%
P/S Ratio
3.63
Revenue / Employee
$769,737
Employees
536
Market Cap
1.53B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023331.41M60.59M22.37%
Dec 31, 2022270.83M113.66M72.31%
Dec 31, 2021157.17M139.36M782.38%
Dec 31, 202017.81M-31.02M-63.53%
Dec 31, 201948.84M28.18M136.45%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evolent Health 2.46B
Myriad Genetics 823.60M
InMode 423.75M
Dynavax Technologies 260.81M
Travere Therapeutics 203.45M
Nurix Therapeutics 56.42M
Intellia Therapeutics 43.09M
Bicycle Therapeutics 36.90M
Revenue Rankings

BCRX News

More News